Addressing the Missing Links in Cardiovascular Aging

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2024 May 22

PMID 38774249

Authors

Elliot Dinetz

Claudia Zeballos-Palacios

Claudia A Martinez

Affiliations

Soon will be listed here.

Abstract

The aim of this manuscript is to provide a review of available options to enhance cardiovascular health and prevent cardiovascular disease (CVD) in the aging population using a systems-biology approach. These include the role of the gut microbiome, the early identification and removal of environmental toxins, and finally age related sex hormones and supplement replacement which all influence aging. Implementing such a comprehensive approach has the potential to facilitate earlier risk assessment, disease prevention, and even improve mortality. Further study in these areas will continue to advance our understanding and refine therapeutic interventions for a healthier cardiovascular aging process.

Citing Articles

Sex Differences in Cardiovascular Diseases: Exploring the Role of Microbiota and Immunity.

Franza L, Caldarelli M, Villani E, Cianci R Biomedicines. 2024; 12(8).

PMID: 39200110 PMC: 11352091. DOI: 10.3390/biomedicines12081645.

References

Blum N, Blum A . Beneficial effects of sauna bathing for heart failure patients. Exp Clin Cardiol. 2008; 12(1):29-32. PMC: 2359619. View

Nagpal R, Mainali R, Ahmadi S, Wang S, Singh R, Kavanagh K . Gut microbiome and aging: Physiological and mechanistic insights. Nutr Healthy Aging. 2018; 4(4):267-285. PMC: 6004897. DOI: 10.3233/NHA-170030. View

Ravalli F, Parada X, Ujueta F, Pinotti R, Anstrom K, Lamas G . Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review. J Am Heart Assoc. 2022; 11(6):e024648. PMC: 9075296. DOI: 10.1161/JAHA.121.024648. View

Arboleya S, Watkins C, Stanton C, Ross R . Gut Bifidobacteria Populations in Human Health and Aging. Front Microbiol. 2016; 7:1204. PMC: 4990546. DOI: 10.3389/fmicb.2016.01204. View

Houston M . The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease. Ther Adv Cardiovasc Dis. 2018; 12(3):85-108. PMC: 5933539. DOI: 10.1177/1753944717743920. View

Dhingra R, Vasan R . Age as a risk factor. Med Clin North Am. 2012; 96(1):87-91. PMC: 3297980. DOI: 10.1016/j.mcna.2011.11.003. View

Lamas G, Ujueta F, Navas-Acien A . Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met. J Am Heart Assoc. 2021; 10(10):e018692. PMC: 8200701. DOI: 10.1161/JAHA.120.018692. View

Hutchings D, Anderson S, Caldwell J, Trafford A . Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?. Heart. 2018; 104(15):1244-1250. PMC: 6204975. DOI: 10.1136/heartjnl-2017-312865. View

Cervantes Gracia K, Llanas-Cornejo D, Husi H . CVD and Oxidative Stress. J Clin Med. 2017; 6(2). PMC: 5332926. DOI: 10.3390/jcm6020022. View

10.

Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F . Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol. 2005; 96(2):95-108. PMC: 1974841. DOI: 10.1016/j.jsbmb.2005.02.014. View

11.

Wong R, Berry N, Coates A, Buckley J, Bryan J, Kunz I . Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens. 2013; 31(9):1819-27. DOI: 10.1097/HJH.0b013e328362b9d6. View

12.

Stampfer M, Colditz G, Willett W, Manson J, Rosner B, Speizer F . Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991; 325(11):756-62. DOI: 10.1056/NEJM199109123251102. View

13.

Khot U, Khot M, Bajzer C, Sapp S, Ohman E, Brener S . Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003; 290(7):898-904. DOI: 10.1001/jama.290.7.898. View

14.

Malik M, Suboc T, Tyagi S, Salzman N, Wang J, Ying R . Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease. Circ Res. 2018; 123(9):1091-1102. PMC: 6205737. DOI: 10.1161/CIRCRESAHA.118.313565. View

15.

Lamas G, Boineau R, Goertz C, Mark D, Rosenberg Y, Stylianou M . EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. Am Heart J. 2014; 168(1):37-44.e5. PMC: 4069605. DOI: 10.1016/j.ahj.2014.02.012. View

16.

Alizadeh M, Kheirouri S . Curcumin reduces malondialdehyde and improves antioxidants in humans with diseased conditions: a comprehensive meta-analysis of randomized controlled trials. Biomedicine (Taipei). 2019; 9(4):23. PMC: 6855189. DOI: 10.1051/bmdcn/2019090423. View

17.

Bull M, Plummer N . Part 1: The Human Gut Microbiome in Health and Disease. Integr Med (Encinitas). 2016; 13(6):17-22. PMC: 4566439. View

18.

Moludi J, Maleki V, Jafari-Vayghyan H, Vaghef-Mehrabany E, Alizadeh M . Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol. 2020; 47(6):927-939. DOI: 10.1111/1440-1681.13250. View

19.

Gonzalez F, Considine R, Abdelhadi O, Acton A . Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2018; 104(3):934-946. PMC: 6364509. DOI: 10.1210/jc.2018-01143. View

20.

Gordon J, Rubinow D, Watkins L, Hinderliter A, Caughey M, Girdler S . The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease. J Clin Endocrinol Metab. 2019; 105(5). PMC: 7096310. DOI: 10.1210/clinem/dgz262. View